190 related articles for article (PubMed ID: 22076927)
1. Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses.
Carvello M; Petrelli A; Vergani A; Lee KM; Tezza S; Chin M; Orsenigo E; Staudacher C; Secchi A; Dunussi-Joannopoulos K; Sayegh MH; Markmann JF; Fiorina P
Diabetes; 2012 Jan; 61(1):155-65. PubMed ID: 22076927
[TBL] [Abstract][Full Text] [Related]
2. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
3. TIM4 Regulates the Anti-Islet Th2 Alloimmune Response.
Vergani A; Gatti F; Lee KM; D'Addio F; Tezza S; Chin M; Bassi R; Tian Z; Wu E; Maffi P; Ben Nasr M; Kim JI; Secchi A; Markmann JF; Rothstein DM; Turka LA; Sayegh MH; Fiorina P
Cell Transplant; 2015; 24(8):1599-1614. PubMed ID: 24612609
[TBL] [Abstract][Full Text] [Related]
4. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
5. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
6. A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.
Vergani A; D'Addio F; Jurewicz M; Petrelli A; Watanabe T; Liu K; Law K; Schuetz C; Carvello M; Orsenigo E; Deng S; Rodig SJ; Ansari JM; Staudacher C; Abdi R; Williams J; Markmann J; Atkinson M; Sayegh MH; Fiorina P
Diabetes; 2010 Sep; 59(9):2253-64. PubMed ID: 20805386
[TBL] [Abstract][Full Text] [Related]
7. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
8. B-cell depletion improves islet allograft survival with anti-CD45RB.
Lee KM; Yeh H; Zhao G; Wei L; O'Connor M; Stott RT; Soohoo J; Dunussi K; Fiorina P; Deng S; Markmann JF; Kim JI
Cell Transplant; 2014 Jan; 23(1):51-8. PubMed ID: 23192154
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
[TBL] [Abstract][Full Text] [Related]
11. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
Rivereau AS; You S; Lalain S; Gouin E; Saï P
Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
[TBL] [Abstract][Full Text] [Related]
12. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice.
Okitsu T; Bartlett ST; Hadley GA; Drachenberg CB; Farney AC
Am J Transplant; 2001 Jul; 1(2):138-45. PubMed ID: 12099361
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
14. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP; Li L; Frelinger JA; Tisch R
J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
[TBL] [Abstract][Full Text] [Related]
15. Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF.
Parsons RF; Yu M; Vivek K; Zekavat G; Rostami SY; Ziaie AS; Luo Y; Koeberlein B; Redfield RR; Ward CD; Migone TS; Cancro MP; Naji A; Noorchashm H
Transplantation; 2012 Apr; 93(7):676-85. PubMed ID: 22262127
[TBL] [Abstract][Full Text] [Related]
16. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
[TBL] [Abstract][Full Text] [Related]
17. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
18. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs.
Safley SA; Kapp JA; Weber CJ
Cell Transplant; 2002; 11(7):695-705. PubMed ID: 12518896
[TBL] [Abstract][Full Text] [Related]
19. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
20. Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.
Mangada J; Pearson T; Brehm MA; Wicker LS; Peterson LB; Shultz LD; Serreze DV; Rossini AA; Greiner DL
Diabetes; 2009 Jan; 58(1):165-73. PubMed ID: 18984741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
